Capstone Holding
CAPS · OTC
$2.66−$0.06 (−2.21%)TodayMarket closed ·
Prev close $2.72
EPS: actual vs estimate
Beat the estimate in 1 of the last 8 quarters, by 58.1% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $0.1224 | $0.083 | −32.2% |
| Q1 FY26 | -$0.1938 | -$0.21 | −8.4% |
| Q4 FY25 | -$0.1326 | -$1.95 | −1370.6% |
| Q3 FY25 | $0.1224 | -$0.12 | −198.0% |
| Q2 FY25 | -$0.0714 | -$0.13 | −82.1% |
| Q1 FY25 | -$1.12 | -$0.47 | +58.1% |
| Q3 FY06 | -$51.00 | -$140.00 | −174.5% |
| Q2 FY06 | -$153.00 | -$160.00 | −4.6% |
Earnings calls
- Capstone Therapeutics' (CAPS) CEO Jock Holliman Hosts Investor Conference
- Earnings call Q3 2014
- Earnings call Q2 2014
- Special Call - Capstone Therapeutics Corp.
- Special Call - Capstone Therapeutics Corp.
- OrthoLogic: The Wall Street Analyst Forum Presentation Transcript
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.